Literature DB >> 7715464

Estrogen and urinary incontinence in women.

C J Sultana1, M D Walters.   

Abstract

OBJECTIVE: The purpose of this study was to review the efficacy of estrogen therapy for urinary incontinence by examining published trials and to review the epidemiologic and physiologic evidence for its action. DATA SOURCES: Controlled and uncontrolled trials of estrogen therapy in the English literature were collected. Eight controlled and 14 uncontrolled trials were identified. METHODS OF STUDY SELECTION: Trials were selected if they were prospective. All types of estrogen treatment were included. All types of outcome measurements were included. DATA EXTRACTION AND SYNTHESIS: Trials were categorized by type of estrogen used; outcome variables (subjective improvement vs objective urodynamic data); and cure/improvement rates.
CONCLUSIONS: Published trials do not support estrogen replacement as efficacious therapy for stress urinary incontinence. It may be useful for incontinence associated with urgency and frequency. Adequately large controlled trials that evaluate estrogen replacement regimens used in the USA remain to be done.

Entities:  

Mesh:

Year:  1994        PMID: 7715464     DOI: 10.1016/0378-5122(94)90008-6

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  9 in total

Review 1.  Effect of SERMs on the uterus and menopausal symptoms.

Authors:  M Dören
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  A study assessing the quality of life related to voiding symptoms and sexual functions in menopausal women.

Authors:  Ji Youn Chun; Kweon Sik Min; Dong Il Kang
Journal:  Korean J Urol       Date:  2011-12-20

3.  Duloxetine: a new pharmacologic therapy for stress urinary incontinence.

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2004

Review 4.  Pharmacotherapy for stress urinary incontinence : present and future options.

Authors:  Norman R Zinner; Stephanie C Koke; Lars Viktrup
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Vulvovaginal atrophy.

Authors:  Maire B Mac Bride; Deborah J Rhodes; Lynne T Shuster
Journal:  Mayo Clin Proc       Date:  2010-01       Impact factor: 7.616

6.  Sexual Health in the Elderly Population.

Authors:  John S Fisher; Andrew Rezk; Elie Nwefo; John Masterson; Ranjith Ramasamy
Journal:  Curr Sex Health Rep       Date:  2020-10-29

Review 7.  The impact of detrusor overactivity on the management of stress urinary incontinence in women.

Authors:  H Henry Lai; Michael Simon; Timothy B Boone
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

Review 8.  Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.

Authors:  David F Archer; Bruce R Carr; JoAnn V Pinkerton; Hugh S Taylor; Ginger D Constantine
Journal:  Menopause       Date:  2015-07       Impact factor: 2.953

Review 9.  Treatment of mixed urinary incontinence.

Authors:  Alex Gomelsky; Roger R Dmochowski
Journal:  Cent European J Urol       Date:  2011-09-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.